Literature DB >> 28197447

Quality of life in different geographic areas; sharing an experience.

Behzad Einollahi1, Mohsen Motalebi1.   

Abstract

Entities:  

Keywords:  Dialysis; Kidney disease; Quality of life

Year:  2013        PMID: 28197447      PMCID: PMC5297555     

Source DB:  PubMed          Journal:  J Nephropharmacol        ISSN: 2345-4202


× No keyword cloud information.

Implication for health policy/practice/research/medical education:

Various factors such as perception of social support, expectations of life, healthy behaviors and outlooks, religious conviction may affect quality of life in dialysis patients. Recently much attention had been directed toward the quality of life in dialysis patients. The published article by Cavalcante et al., titled “factors associated with the quality of life of adults subjected to hemodialysis in a city in northeast Brazil”(1), has focused on exploration of socioeconomic, demographic, clinical and laboratory factors that can affect quality of life (QoL) in hemodialysis (HD) patients in Brazil. We have also conducted a study to evaluate QoL on 6930 HD patients in Iran (2) applying the kidney disease component summary - Short Form 1.3 questionnaire (KDCS-SF). We would like to share our experience that may be helpful to others. Cavalcante et al. (1) found employment status, burden of kidney disease, general health, patient satisfaction and physical function were the domains with worsen QoL (≤50). We have also shown work status, burden of kidney disease, general health and physical function were the domains with worsen QoL (2) as well as role physical, role emotional and energy\fatigue as shown in Table 1, of course with lower scores compared to current study (2). The low scores of physical domains in both studies obviously show that spending many times for hemodialysis can affect and disturb patient’s daily activities every week. In addition, majority of QoL domains scores among our HD patients were lower than patients on Cavalcante et al. study, which indicated the difference of perception of QoL between two countries’ people. Kutner et al. showed there are differences between QoL between white and black races (3). So it seems many factors such as perception of social support, expectations of life, healthy behaviors and outlooks, religious conviction and etc. are different among countries. It is interest of that Cavalcante et al. showed gender had no effect on HD patients’ QoL, while we showed better QoL in males than that of females. Zender et al. (4) also reported a lower QoL in women when compared to men; in addition, they showed a high prevalence of psychological disorders with more severity that it can lead to lower QoL in females. We think it is due to differences of male roles in family and community between both countries. Although the current study shows dialysis duration has no effect on patients QoL, we found that there was the significant correlation between QoL and dialysis duration (2) so that more dialysis duration patients had lower QoL. Bayoumi et al. also considered that dialysis duration was a negative predictor for QoL (5). This different outcome may be due to two reasons: 1) patients older than 60 years old were 39.7% in our study while all of patients in the present study (1) were younger than this. 2) patients size in the present study (1) was smaller compared to our study which had a huge number of patients. Finally, we suggest a multi-center study or a meta-analysis to evaluate QoL in different countries to determine whether different geographic areas have effect on QoL or not.
Table 1

Mean and Standard Deviation, of KDQOL-SF and SF-36 Items (Ref. 2)

Mean ± SD
Symptoms 67.9 ± 19.8
Effects of kidney disease50.42 ± 20.9
Burden of kidney disease23.08 ± 19.78
Work status22.3 ± 34.56
Cognitive function66.26 ± 21.21
Quality of social interaction 67.07 ± 20.08
Sexual function63.48 ± 30.4
Sleep 55.9 ± 19.9
Social support72.8 ± 26.9
Dialysis staff encouragement81.3 ± 21.87
Patient satisfaction69.01 ± 24.24
Kidney disease component summary (KDCS)57.97 ± 11.7
Physical function40.46 ± 29.5
Rolephysical 25.6 ± 32.7
Pain55.31 ± 25.73
General health41.70 ± 19.71
Physical component summary (PCS)40.79 ± 20.1
Emotional well-being 54.24 ± 18.03
Role emotional36.28 ± 38.89
Social function 55.77 ± 22.3
Energy/ fatigue 44.76 ± 19.79
Mental component summary (MCS)47.79 ± 18.31
SF-3644.29 ± 17.7
SF-36 + KDCS51.12 ± 13.41

Authors’ contributions

All authors contributed to study equally.

Ethical considerations

Ethical issues (including plagiarism, informed consent, misconduct, double publication and redundancy) have been completely observed by authors.

Conflict of interests

The authors declared no competing interests.

Funding/Support

No funding from any source.
  5 in total

1.  Race, gender, and incident dialysis patients' reported health status and quality of life.

Authors:  Nancy G Kutner; Rebecca Zhang; Donna Brogan
Journal:  J Am Soc Nephrol       Date:  2005-03-30       Impact factor: 10.121

2.  Predictors of quality of life in hemodialysis patients.

Authors:  Magda Bayoumi; Ali Al Harbi; Abdulkareem Al Suwaida; Mohammed Al Ghonaim; Jamal Al Wakeel; Adel Mishkiry
Journal:  Saudi J Kidney Dis Transpl       Date:  2013-03

3.  Factors associated with the quality of life of adults subjected to hemodialysis in a city in northeast Brazil.

Authors:  Milady Cutrim Vieira Cavalcante; Zeni Carvalho Lamy; Fernando Lamy Filho; Ana Karina Teixeira da Cunha França; Alcione Miranda dos Santos; Erika Bárbara Abreu Fonseca Thomaz; Antonio Augusto Moura da Silva; Natalino Salgado Filho
Journal:  J Bras Nefrol       Date:  2013 Apr-Jun

Review 4.  Women's mental health: depression and anxiety.

Authors:  Robynn Zender; Ellen Olshansky
Journal:  Nurs Clin North Am       Date:  2009-09       Impact factor: 1.208

5.  Health-related quality of life in hemodialysis patients: an Iranian multi-center study.

Authors:  Zohreh Rostami; Behzad Einollahi; Mahboob Lessan-Pezeshki; Azam Soleimani Najaf Abadi; Susan Mohammadi Kebar; Heshmatollah Shahbazian; Atieh Makhlough; Khadijeh Makhdoomi; Mahmood Salesi; Mojgan Jalalzadeh
Journal:  Nephrourol Mon       Date:  2013-08-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.